Eikon Therapeutics, Inc.
EIKN
$12.31
$0.786.77%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -79.66M | -64.92M | |||
| Total Depreciation and Amortization | 5.11M | 6.22M | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 3.21M | 1.74M | |||
| Change in Net Operating Assets | 29.62M | 33.23M | |||
| Cash from Operations | -41.72M | -23.74M | |||
| Capital Expenditure | -66.00K | -39.52M | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 40.78M | 47.67M | |||
| Cash from Investing | 40.71M | 8.15M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 1.09M | 95.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | 0.00 | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 1.09M | 95.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 75.00K | -15.49M | |||